Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

RxSight, Inc. - Common Stock (NQ:RXST)

5.800 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.800
Bid (Size) 5.600 (100)
Ask (Size) 6.700 (10,000)
Prev. Close 5.800
Today's Range 5.800 - 5.800
52wk Range 5.300 - 16.74
Shares Outstanding 33,981,877
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RxSight (NASDAQ:RXST) Q1 2026 Results: Revenue Beats but Loss Widens Amid Cautious Market Reaction ↗
Via Chartmill
News headline image
RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook
From RxSight, Inc.
Via GlobeNewswire

Performance

YTD
-44.1%
-44.1%
1 Month
-14.2%
-14.2%
3 Month
-25.8%
-25.8%
6 Month
-32.6%
-32.6%
1 Year
-61.1%
-61.1%

More News

Read More
News headline image
RxSight, Inc. to Present at the Bank of America Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RXSIGHT INC (NASDAQ:RXST) Reports Q4 Beat but Cautious 2026 Outlook Weighs on Shares ↗
Via Chartmill
News headline image
Earnings Scheduled For November 5, 2025 ↗
Via Benzinga
News headline image
RxSight (RXST) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
From RxSight, Inc.
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
From Pomerantz LLP
Via GlobeNewswire
News headline image
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
From RxSight, Inc.
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
From Pomerantz LLP
Via GlobeNewswire
News headline image
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
From Pomerantz LLP
Via GlobeNewswire
News headline image
RxSight, Inc. Announces Chief Financial Officer Transition
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
RxSight, Inc. Reports Third Quarter 2025 Financial Results
From RxSight, Inc.
Via GlobeNewswire
News headline image
Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence
Via MarketMinute
Topics Earnings Supply Chain
News headline image
RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting
From RxSight, Inc.
Via GlobeNewswire
News headline image
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. is Investigating RxSight, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Frequently Asked Questions

Is RxSight, Inc. - Common Stock publicly traded?
Yes, RxSight, Inc. - Common Stock is publicly traded.
What exchange does RxSight, Inc. - Common Stock trade on?
RxSight, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for RxSight, Inc. - Common Stock?
The ticker symbol for RxSight, Inc. - Common Stock is RXST on the Nasdaq Stock Market
What is the current price of RxSight, Inc. - Common Stock?
The current price of RxSight, Inc. - Common Stock is 5.800
When was RxSight, Inc. - Common Stock last traded?
The last trade of RxSight, Inc. - Common Stock was at 05/07/26 04:00 PM ET
What is the market capitalization of RxSight, Inc. - Common Stock?
The market capitalization of RxSight, Inc. - Common Stock is 197.09M
How many shares of RxSight, Inc. - Common Stock are outstanding?
RxSight, Inc. - Common Stock has 197M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.